Cubist Systematic Strategies’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Cubist Systematic Strategies’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,757	Closed	-$40K	–	3698
2021 Q3	$40K	Buy	+1,757	New	+$52.3K	﹤0.01%	2855
2021 Q1	–	Sell	-1,103	Closed	-$48K	–	3013
2020 Q4	$48K	Buy	+1,103	New	+$49.4K	﹤0.01%	2470
2020 Q3	–	Sell	-4,677	Closed	-$281K	–	2687
2020 Q2	$281K	Buy	+4,677	New	+$428K	﹤0.01%	1876
2019 Q4	–	Sell	-68	Closed	-$8K	–	2589
2019 Q3	$8K	Buy	+68	New	+$9.49K	﹤0.01%	2156

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Cubist Systematic Strategies's ORTX Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 1,757 shares — an estimated $40K sold.

Cubist Systematic Strategies first reported a position in ORTX in Q3 2019 and held it in 4 quarters. The position peaked at $281K in Q2 2020. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Cubist Systematic Strategies reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 1,757 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $40K.
Cubist Systematic Strategies first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 4 quarters.
Cubist Systematic Strategies's Orchard Therapeutics plc American Depositary Shares position peaked at $281K in Q2 2020.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.